LexaGene: Automated, Rapid Pathogen Detection
LexaGene is a molecular diagnostics company. In fact, they're developing a fully automated, rapid pathogen detection system for use at the point-of-ne …
MiQLab automated pathogen detection system
LexaGene is a molecular diagnostics company. In fact, they're developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected. Further, the system offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.
More on MiQLab
LexaGene’s MiQLab™ system aims to transform pathogen detection in multi-billion-dollar-markets.
MiQLab brings reference laboratory quality data to the point-of-need where samples are collected—to quickly detect multiple pathogens at once with sensitivity and specificity—and return results in ~1 hour. MiQLab is an automated, multiplexing PCR-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.
For more information on LexaGene Holdings, Inc., (TSX.V: LXG, OTCQB: LXXGF) please fill out the form below.
Latest Articles
.png)
Hot Companies
You might also like
Harvest ETFs: Expanding Income Opportunities with New High-Income Shares - HHIS
Harvest ETFs introduces five new high-income single-stock ETFs, offering investors exposure to leading companies like MicroStrategy, Coinbase, Tesla, Meta, and Palantir—all with the benefit of consistent monthly income.
.png)
